Nath Bio-Genes (India) Ltd

Nath Bio-Genes Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Nath Bio-Genes (India) Ltd

₹ 210 -2.40%
04 Oct - close price
nathbiogenes.com BSE: 537291 NSE: NATHBIOGEN
About

Incorporated in 1993, Nath Bio-Genes Ltd
is in the business of Production, Processing,
and Marketing of Hybrid and GM Seeds[1]

Key Points

Business Overview:[1][2][3]
NBGL is a flagship company of Nath Group.
It is an agri-tech company in the business of developing and supplying quality BT, hybrid, and varietal seeds to farmers at affordable prices. It does the production and processing of commercial and vegetable seeds on lands taken on lease from various growers /farmers throughout India. The company enters into seed production agreements with these farmers/growers and compensates them for various cultivation expenses based on the rate agreement entered into

Website BSE NSE - BE
  • Market Cap ₹ 392 Cr.
  • Current Price ₹ 210
  • High / Low ₹ 264 / 167
  • Stock P/E 10.0
  • Book Value ₹ 321
  • Dividend Yield 0.95 %
  • ROCE 6.85 %
  • ROE 6.23 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Stock is trading at 0.65 times its book value

Cons

  • The company has delivered a poor sales growth of 3.74% over past five years.
  • Tax rate seems low
  • Company has a low return on equity of 5.55% over last 3 years.
  • Dividend payout has been low at 4.87% of profits over last 3 years

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Miscellaneous Industry: Miscellaneous

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024
215 15 22 27 209 22 25 45 235 23 32 43 244
167 10 16 48 175 17 20 41 198 17 26 39 207
Operating Profit 49 5 6 -21 34 5 6 4 37 5 6 4 37
OPM % 23% 32% 29% -78% 16% 22% 22% 9% 16% 23% 18% 10% 15%
0 0 0 -88 0 0 0 0 0 0 3 1 0
Interest 3 3 3 2 3 3 3 2 3 2 3 1 2
Depreciation 1 1 1 1 1 1 1 1 1 1 1 1 1
Profit before tax 45 1 3 -113 31 2 2 2 34 2 5 4 34
Tax % 1% 8% 3% 3% 1% 4% 34% 13% 1% 18% 16% 16% 1%
45 1 3 -116 31 1 1 2 33 2 4 3 34
EPS in Rs 23.63 0.65 1.48 -61.19 16.19 0.77 0.71 0.84 17.58 0.84 2.08 1.69 17.83
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
109 136 143 127 142 171 206 246 271 230 234 248 341
89 102 109 103 113 131 163 191 204 193 185 197 289
Operating Profit 20 34 35 25 29 40 43 55 67 37 49 50 52
OPM % 18% 25% 24% 19% 20% 24% 21% 22% 25% 16% 21% 20% 15%
1 1 1 1 0 1 2 2 2 -87 1 4 4
Interest 4 4 5 6 10 10 5 7 9 11 10 9 9
Depreciation 5 5 4 4 3 1 1 1 3 3 3 3 3
Profit before tax 12 26 26 15 17 30 39 49 57 -63 36 42 45
Tax % 4% 5% 4% 6% 3% 2% 1% -4% 2% 6% 3% 5%
12 24 25 14 16 29 38 50 56 -67 35 40 43
EPS in Rs 7.34 15.18 15.87 8.85 10.17 15.48 20.22 26.56 29.29 -35.43 18.51 21.14 22.44
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 7% -6% 11% 9%
Compounded Sales Growth
10 Years: 6%
5 Years: 4%
3 Years: -3%
TTM: 4%
Compounded Profit Growth
10 Years: 4%
5 Years: -1%
3 Years: -13%
TTM: 4%
Stock Price CAGR
10 Years: 4%
5 Years: -9%
3 Years: -14%
1 Year: 2%
Return on Equity
10 Years: 8%
5 Years: 7%
3 Years: 6%
Last Year: 6%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 16 16 16 16 16 19 19 19 19 19 19 19
Reserves 41 66 91 105 287 450 489 539 594 523 554 592
19 23 22 59 74 33 58 70 101 93 105 108
67 85 97 87 78 69 80 102 75 105 114 158
Total Liabilities 143 190 226 267 455 571 646 730 790 740 793 877
18 17 13 30 207 211 232 246 247 245 244 249
CWIP 0 0 0 0 0 0 0 0 0 0 0 0
Investments 5 5 5 5 5 5 5 5 5 5 5 6
120 168 208 231 243 355 409 479 538 490 544 622
Total Assets 143 190 226 267 455 571 646 730 790 740 793 877

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
15 6 -14 3 -47 -23 9 1 17 38 75
-16 -2 -17 -4 -4 -20 -14 -10 -20 -3 -27
1 -4 30 5 90 20 6 16 -22 -2 -10
Net Cash Flow -0 -1 -0 5 39 -23 1 7 -25 34 38

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 70 95 114 130 133 175 191 159 147 136 152 139
Inventory Days 3,840 4,743 4,388
Days Payable 1,309 1,406 586
Cash Conversion Cycle 70 95 114 130 2,665 3,512 191 159 147 136 3,954 139
Working Capital Days 167 179 242 383 398 515 544 519 585 573 578 498
ROCE % 24% 33% 26% 14% 10% 9% 8% 9% 10% 5% 7% 7%

Shareholding Pattern

Numbers in percentages

Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
41.03% 41.03% 41.05% 41.07% 45.59% 45.59% 45.59% 45.59% 45.59% 45.59% 45.59% 45.59%
0.01% 0.04% 0.07% 0.11% 0.01% 0.15% 0.13% 0.07% 0.22% 0.32% 0.27% 0.21%
9.38% 7.17% 4.85% 4.62% 4.62% 4.62% 4.62% 4.62% 4.37% 4.37% 4.37% 4.37%
49.58% 51.76% 54.02% 54.20% 49.77% 49.62% 49.65% 49.71% 49.81% 49.72% 49.76% 49.80%
No. of Shareholders 33,27233,92635,61035,48435,47034,74933,96033,50234,36534,26335,13235,834

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls